Overview
Encompassing the broad spectrum of epigenetics research from basic research to innovations in therapeutic treatments, Clinical Epigenetics is a top tier, open access journal devoted to the study of epigenetic principles and mechanisms as applied to human development, disease, diagnosis and treatment. With a wide range of specialized sections and dedicated Section Editors, authors can be assured that their manuscript is being reviewed by experts in the field. The journal particularly welcomes submissions involving clinical trials, translational research, new and innovative methodologies and mechanistic insights provided by model organisms.
- Editors-in-Chief
-
- Lucia Altucci MD, PhD
- Marianne Rots PhD
Societies and partnerships
Journal metrics
- Journal Impact Factor
- 5.7 (2025)
- 5-year Journal Impact Factor
- 6.0 (2025)
- Submission to first decision (median)
- 7 days
- Downloads
- 2.4M (2025)
Journal highlights
Update
CLEPIC
Clinical Epigenetics International Conference, Barcelona, Spain, June 10 – 12, 2026 https://www.clepic.org
Calls for papers
Collection
CLEPIC 2026: Advances and Emerging Directions in Clinical Epigenetics
This Collection brings together invited contributions from CLEPIC 2026, highlighting advances in molecular and clinical epigenetics, with...
- Status
- Open for submissions
- Submission deadline
- 28 February 2027
Collection
Artificial Intelligence and Advanced Technologies in Clinical Epigenetics
Clinical epigenetics investigates how epigenetic modifications, such as DNA methylation, histone modifications, and chromatin remodeling, shape...
- Status
- Open for submissions
- Submission deadline
- 12 October 2026
Collection
Pollution and Epigenetics
From diesel particulates to endocrine disruptors, asbestos, heavy metals to molecules like bisphenol A (BPA), it is becoming increasingly clear...
- Status
- Open for submissions
- Submission deadline
- Ongoing
Latest articles
-
Epigenetics-mediated pathological alterations and their diagnostic and therapeutic potential in sepsis-associated acute kidney injury
- Qian Zhang
- Yuan Tan
- Liyan Cui
Review Open access 30 June 2026 -
Genetic and epigenetic underpinnings of biological aging: a multi-omics study integrating Mendelian randomization, spatial transcriptomics, and drug target discovery
- Chun Zhang
- Jingqi Zhang
Research Open access 24 June 2026 -
Epigenetic collapse establishes transcriptional bottlenecks in malignant rhabdoid tumor
- Tatsuya Masuda
- Takayoshi Watanabe
- Yasuhiko Kamikubo
Review Open access 24 June 2026
-
Histone lactylation: a novel epigenetic bridge linking cellular metabolism to benign and malignant gynecological diseases
- Wanhui You
- Siyu Wang
- Ying Guo
Review Open access 23 June 2026 -
ATAD2 suppresses senescence and SASP via SIRT7-p53/p21 to drive progression and immune evasion in endometrial cancer
- Can Wang
- Anastasiia Osipova
- Xiuwei Chen
Research Open access 21 June 2026
Journal updates
-
-
Clinical Epigenetics follows two specific editorial policies:
- Editorial Policy Regarding Submissions Focusing on Non-coding RNAs or RNA Modifications
- Editorial Policy Regarding Submissions Focusing on Reanalysis of Publicly Available Data and In Silico Approaches
Please review these policies before submitting your manuscript to the journal.
-
-
CLEPIC
Clinical Epigenetics International Conference, Barcelona, Spain, June 10 – 12, 2026
Journal information
- Electronic ISSN
- 1868-7083
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Chinese Academy of Medical Science (CAMS)
- DOAJ
- Dimensions
- EMBASE
- EMBiology
- Gale
- GoOA - The Chinese Academy of Sciences (CAS)
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Ovid Discovery
- Portico
- ProQuest
- PubMedCentral
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- Wanfang
- eLibrary.ru
- © BioMed Central Ltd., part of Springer Nature